BIORESTORATIVE THERAPIES, INC. Increase Decrease In Operating Lease Liability
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Increase Decrease In Operating Lease Liability of -$162.32 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-03-26
- BIORESTORATIVE THERAPIES, INC. increase decrease in operating lease liability for the quarter ending 2024-12-31 was -$42.41K.
- BIORESTORATIVE THERAPIES, INC. increase decrease in operating lease liability for the quarter ending 2024-09-30 was -$41.17K.
- BIORESTORATIVE THERAPIES, INC. increase decrease in operating lease liability for the quarter ending 2024-06-30 was -$39.96K.
- BIORESTORATIVE THERAPIES, INC. increase decrease in operating lease liability for the quarter ending 2024-03-31 was -$38.78K.
- BIORESTORATIVE THERAPIES, INC. increase decrease in operating lease liability for fiscal 2024 was -$162.32K.
- BIORESTORATIVE THERAPIES, INC. increase decrease in operating lease liability for fiscal 2023 was -$139.33K.
- BIORESTORATIVE THERAPIES, INC. increase decrease in operating lease liability for fiscal 2022 was -$163.13K.
- BIORESTORATIVE THERAPIES, INC. increase decrease in operating lease liability for fiscal 2021 was -$101.19K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$42.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$83.58K derived: sum of 2 quarters · filed 2026-03-26 | -$123.54K derived: sum of 3 quarters · filed 2026-03-26 | -$162.32K 10-K · filed 2026-03-26 |
| 2024-09-30 | -$41.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$81.12K derived: sum of 2 quarters · filed 2025-11-12 | -$119.90K 10-Q · filed 2025-11-12 | -$156.31K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$39.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$78.74K 10-Q · filed 2025-08-12 | -$115.14K derived: sum of 3 quarters · filed 2025-08-12 | -$150.48K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$38.78K 10-Q · filed 2025-05-14 | -$75.19K derived: sum of 2 quarters · filed 2025-05-14 | -$110.52K derived: sum of 3 quarters · filed 2025-05-14 | -$144.82K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$36.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$71.74K derived: sum of 2 quarters · filed 2025-03-28 | -$106.04K derived: sum of 3 quarters · filed 2025-03-28 | -$139.33K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$35.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$69.63K derived: sum of 2 quarters · filed 2024-11-12 | -$102.92K 10-Q · filed 2024-11-12 | -$178.11K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$34.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$67.58K 10-Q · filed 2024-08-13 | -$142.77K derived: sum of 3 quarters · filed 2024-08-13 | -$172.97K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$33.29K 10-Q · filed 2024-06-11 | -$108.47K derived: sum of 2 quarters · filed 2024-06-11 | -$138.67K derived: sum of 3 quarters · filed 2024-06-11 | -$167.98K derived: sum of 4 quarters · filed 2024-06-11 |
| 2022-12-31 | -$75.19K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-06-11 | -$105.38K derived: sum of 2 quarters · filed 2024-06-11 | -$134.69K derived: sum of 3 quarters · filed 2024-06-11 | -$163.13K 10-K/A · filed 2024-06-11 |
| 2022-09-30 | -$30.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$59.50K derived: sum of 2 quarters · filed 2023-11-13 | -$87.94K 10-Q · filed 2023-11-13 | -$114.39K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$29.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$57.75K 10-Q · filed 2023-08-11 | -$84.19K derived: sum of 3 quarters · filed 2023-08-11 | -$109.86K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$28.44K 10-Q · filed 2023-05-12 | -$54.88K derived: sum of 2 quarters · filed 2023-05-12 | -$80.55K derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$26.44K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$52.10K derived: sum of 2 quarters · filed 2023-03-27 | -$101.19K 10-K · filed 2023-03-27 | |
| 2021-09-30 | -$25.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$74.75K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$49.09K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |